ED
CLMT icon

Exane Derivatives’s Calumet Specialty Products CLMT Stock Holding History

Exane Derivatives’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-260
Closed -$925 – 671
2019
Q1 		$925 Buy
260
+139
+115% +$462 ﹤0.01% 503
2018
Q4 		$267 Hold
121
– – ﹤0.01% 624
2018
Q3 		$771 Hold
121
– – ﹤0.01% 559
2018
Q2 		$913 Sell
121
-4
-3% -$30 ﹤0.01% 536
2018
Q1 		$868 Buy
125
+52
+71% +$384 ﹤0.01% 482
2017
Q4 		$562 Sell
73
-96
-57% -$800 ﹤0.01% 502
2017
Q3 		$1.41K Sell
169
-48
-22% -$299 ﹤0.01% 449
2017
Q2 		$922 Buy
217
+20
+10% +$80 ﹤0.01% 482
2017
Q1 		$748 Buy
197
+54
+38% +$214 ﹤0.01% 420
2016
Q4 		$572 Buy
143
+20
+16% +$82 ﹤0.01% 483
2016
Q3 		$555 Buy
123
+21
+21% +$108 ﹤0.01% 488
2016
Q2 		$500 Buy
102
+42
+70% +$238 ﹤0.01% 435
2016
Q1 		$705 Hold
60
– – ﹤0.01% 482
2015
Q4 		$1.19K Hold
60
– – ﹤0.01% 396
2015
Q3 		$1.46K Sell
60
-315
-84% -$8.18K ﹤0.01% 411
2015
Q2 		$9.55K Hold
375
– – ﹤0.01% 366
2015
Q1 		$9.02K Sell
375
-377
-50% -$9.54K ﹤0.01% 381
2014
Q4 		$16.9K Buy
+752
New +$19.6K ﹤0.01% 395

Other funds holding CLMT

AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
WWM
Windsor Wealth Management Indianapolis, Indiana $546M AUM 16.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BC
Barnett & Company Chattanooga, Tennessee $129M AUM 14.9% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SCM
Springhouse Capital Management Westport, Connecticut $55.3M AUM 20.84% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Exane Derivatives's CLMT Position: Q2 2019 in Review

Exane Derivatives sold out of Calumet Specialty Products (CLMT) in Q2 2019, closing a stake of 260 shares — an estimated $925 sold.

Exane Derivatives first reported a position in CLMT in Q4 2014 and held it in 18 quarters. The position peaked at $16.9K in Q4 2014. 66 funds tracked by Wall St. Rank hold CLMT as of Q2 2019.

  • Exane Derivatives reported no remaining Calumet Specialty Products position as of Q2 2019 after selling out during the quarter.
  • Exane Derivatives sold 260 Calumet Specialty Products shares in Q2 2019, an estimated $925.
  • Exane Derivatives first reported a position in Calumet Specialty Products in Q4 2014 and held it in 18 quarters.
  • Exane Derivatives's Calumet Specialty Products position peaked at $16.9K in Q4 2014.
  • 66 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2019.

Based on Exane Derivatives's 13F filing for Q2 2019, filed 12 Jul 2019.